Infimer Ltd (INFR) - Net Assets

Latest as of June 2019: ILA6.13 Million ILA ≈ $16.43K USD

Based on the latest financial reports, Infimer Ltd (INFR) has net assets worth ILA6.13 Million ILA (≈ $16.43K USD) as of June 2019. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA13.63 Million ≈ $36.54K USD) and total liabilities (ILA7.50 Million ≈ $20.10K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Infimer Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	ILA6.13 Million
% of Total Assets	44.98%
Annual Growth Rate	N/A
5-Year Change	16.57%
10-Year Change	-23.9%
Growth Volatility	116.75

Infimer Ltd - Net Assets Trend (2005–2018)

This chart illustrates how Infimer Ltd's net assets have evolved over time, based on quarterly financial data. Also explore INFR total asset value for the complete picture of this company's asset base.

Annual Net Assets for Infimer Ltd (2005–2018)

The table below shows the annual net assets of Infimer Ltd from 2005 to 2018. For live valuation and market cap data, see INFR stock market capitalisation.

Year	Net Assets	Change
2018-12-31	ILA8.70 Million ≈ $23.33K	+246.46%
2017-12-31	ILA2.51 Million ≈ $6.73K	-59.08%
2016-12-31	ILA6.14 Million ≈ $16.46K	+45.06%
2015-12-31	ILA4.23 Million ≈ $11.35K	-43.32%
2014-12-31	ILA7.47 Million ≈ $20.02K	-7.12%
2013-12-31	ILA8.04 Million ≈ $21.55K	-33.26%
2012-12-31	ILA12.04 Million ≈ $32.29K	+265.83%
2011-12-31	ILA3.29 Million ≈ $8.83K	-38.00%
2010-12-31	ILA5.31 Million ≈ $14.24K	-53.57%
2009-12-31	ILA11.44 Million ≈ $30.66K	-27.65%
2006-12-31	ILA15.81 Million ≈ $42.38K	+7063.44%
2005-12-31	ILA-227.00K ≈ $-608.58	--

Equity Component Analysis

This analysis shows how different components contribute to Infimer Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 2703900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2018)

Component	Amount	Percentage
Common Stock	ILA18.98 Million	246.32%
Other Components	ILA15.76 Million	204.52%
Total Equity	ILA7.71 Million	100.00%

Infimer Ltd Competitors by Market Cap

The table below lists competitors of Infimer Ltd ranked by their market capitalization.

Company	Market Cap
Stenocare AS CO:STENO	$7.70 Million
Genuit Group plc LSE:GEN	$7.71 Million
Agroz Inc. Ordinary Shares NASDAQ:AGRZ	$7.72 Million
Ssif Broker Cl RO:BRK	$7.72 Million
Fatfish Group Ltd AU:FFG	$7.69 Million
Imperial Pacific Ltd AU:IPC	$7.69 Million
Aptevo Therapeutics Inc NASDAQ:APVO	$7.68 Million
Mountain Province Diamonds Inc TO:MPVD	$7.68 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Infimer Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2017 to 2018, total equity changed from 1,408,000 to 7,707,000, a change of 6,299,000 (447.4%).
Net loss of 8,649,000 reduced equity.
Other factors increased equity by 14,948,000.

Equity Change Factors (2017 to 2018)

Factor	Impact	Contribution
Net Income	ILA-8.65 Million	-112.22%
Other Changes	ILA14.95 Million	+193.95%
Total Change	ILA-	447.37%

Book Value vs Market Value Analysis

This analysis compares Infimer Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently Infimer Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -112.22%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 1.84x
Recent ROE (-112.22%) is below the historical average (-88.49%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	47.58%	1.50%	3.22x	9.82x	ILA3.68 Million
2011	-53.48%	-0.33%	7.16x	22.67x	ILA-1.94 Million
2012	71.32%	2.23%	21.01x	1.52x	ILA7.38 Million
2013	-6.30%	-7.50%	0.83x	1.01x	ILA-1.31 Million
2014	-29.64%	0.00%	0.00x	1.01x	ILA-2.96 Million
2015	-101.16%	0.00%	0.00x	1.40x	ILA-4.70 Million
2016	-135.77%	-37957.89%	0.00x	1.65x	ILA-7.74 Million
2017	-476.78%	-4043.98%	0.02x	5.14x	ILA-6.85 Million
2018	-112.22%	0.00%	0.00x	1.84x	ILA-9.42 Million

Industry Comparison

This section compares Infimer Ltd's net assets metrics with peer companies in the Professional & Commercial Services industry.

Industry Context

Industry: Professional & Commercial Services
Average net assets among peers: $35,879,000
Average return on equity (ROE) among peers: 28.88%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Infimer Ltd (INFR)	ILA6.13 Million	47.58%	1.22x	$7.70 Million
Trendline (TREN)	$35.88 Million	28.88%	0.50x	$19.35 Million

About Infimer Ltd

TA:INFR Israel Professional & Commercial Services

Market Cap

$7.70 Million

ILA2.87 Billion ILA

Market Cap Rank

#27476 Global

#401 in Israel

Share Price

ILA2700.00

Change (1 day)

+0.00%

52-Week Range

ILA1004.00 - ILA7697.00

All Time High

ILA35000.00